Antioxidative Property and Molecular Mechanisms Underlying Geniposide-Mediated Therapeutic Effects in Diabetes Mellitus and Cardiovascular Disease

<div>Schematic diagram of mechanisms of geniposide in diabetes mellitus. TCF7L2: T-cell factor 7-like 2; GLP-1R: glucagon-like peptide-1 receptor; PKA: protein kinase A; cAMP: cyclic adenosine monophosphate; Kv channels: voltage-gated K channels; JAK2: tyrosine kinase 2; P: phosphorylated.</div>

Oxidative Medicine and Cellular Longevity

fig7

Figure 7

Figure 7: Antioxidative Property and Molecular Mechanisms Underlying Geniposide-Mediated Therapeutic Effects in Diabetes Mellitus and Cardiovascular Disease 

Figure 7 | Antioxidative Property and Molecular Mechanisms Underlying Geniposide-Mediated Therapeutic Effects in Diabetes Mellitus and Cardiovascular Disease 